Fmoc-His(3-Bom)-OH

Fmoc-His(3-Bom)-OH is an Fmoc-protected histidine derivative in which the imidazole side chain bears a 3-bromomethyl substituent, preserving the stereochemically defined amino acid backbone while introducing a reactive benzylic-type bromomethyl handle. The molecule contains an N-(9H-fluoren-9-ylmethoxycarbonyl) protecting group on the alpha-amino function, a free carboxylic acid suitable for peptide coupling, and a substituted imidazole that can participate in coordination and hydrogen-bonding interactions during synthetic and biochemical studies. The bromomethyl group can undergo nucleophilic substitution and subsequent functional group installation, enabling controlled side-chain derivatization without disturbing the protected amine. The combination of chiral amino acid architecture, orthogonal protection at the alpha-N, and a halomethyl electrophile makes the compound a practical chiral amino acid intermediate for peptide building block preparation and downstream functionalization.

1. Peptide Synthesis

Fmoc-His(3-Bom)-OH serves as an Fmoc-based histidine side-chain-functionalized building block for solid-phase peptide synthesis and related protected amino acid chemistry. The Fmoc group enables standard N-terminal protection and deprotection cycles, while the free carboxylic acid supports amide bond formation to install the histidine residue at a defined position in a peptide sequence. The 3-bromomethyl-substituted imidazole side chain is compatible with peptide assembly conditions and can be retained for post-coupling side-chain elaboration or transformed into alternative functionalities after chain assembly. Resulting peptide constructs can be used to probe residue-level effects, generate chemically defined analogs, and support synthetic methodology development for side-chain electrophile handling in peptide science.

2. Side-Chain Functionalization

Fmoc-His(3-Bom)-OH is suitable for side-chain functionalization workflows that leverage the bromomethyl electrophile on the imidazole ring substituent. The bromomethyl group can undergo nucleophilic substitution to install thioethers, amines, azides, or other nucleophile-derived linkers, while the imidazole core maintains its aromatic and coordination-capable character for molecular recognition. The presence of the Fmoc-protected alpha-amino group and the carboxylic acid allows orthogonal management of reactivity, enabling selective side-chain chemistry after peptide coupling or after controlled deprotection. Downstream products include functionalized histidine derivatives and peptide conjugation handles that can feed into bioconjugation chemistry, chemical biology probes, and peptidomimetic scaffold elaboration.

3. Bioconjugation Chemistry

Fmoc-His(3-Bom)-OH can be applied to bioconjugation-oriented synthesis where a histidine-based linker or reactive side chain is required for attachment to biomolecules. The substituted imidazole provides a chemically addressable motif that can participate in metal coordination and hydrogen-bonding, while the bromomethyl group enables conversion to bioorthogonal or conjugation-ready moieties through substitution chemistry. The Fmoc-protected amino acid format supports incorporation into peptides or peptide-like constructs that later undergo controlled side-chain derivatization for attachment to proteins, polymers, or targeting ligands. Resulting conjugation-ready intermediates support chemical biology research intermediate preparation and enable construction of defined biomolecule labeling reagents derived from amino acid chemistry.

4. Drug Discovery SAR Studies

Fmoc-His(3-Bom)-OH is suitable for structure-activity relationship studies that require systematic variation of a histidine side-chain electrophile and its downstream substituents. The chiral amino acid backbone and protected alpha-amino group support consistent peptide or peptidomimetic assembly, while the 3-bromomethyl substituent allows rapid generation of analog libraries via nucleophile-driven diversification. The imidazole functionality can influence binding through aromatic stacking, protonation-state effects, and coordination interactions, making side-chain modifications directly relevant to medicinal chemistry SAR mapping. Downstream derivatives prepared from this intermediate can be used as discrete chemical entities for fragment-based molecular design, SAR panel synthesis, and comparative evaluation of side-chain substitution patterns in peptide-like lead series.

5. Pharmaceutical Manufacturing

Fmoc-His(3-Bom)-OH is applicable to pharmaceutical manufacturing workflows that involve protected amino acid synthesis, peptide building block preparation, and controlled intermediate generation for drug substance assembly. The Fmoc protection strategy provides a robust N-protection handle compatible with scalable peptide coupling and subsequent deprotection steps, while the free carboxylic acid supports reliable formation of the required amide linkage in peptide manufacturing routes. The bromomethyl-bearing imidazole side chain can be managed as a functional-group intermediate for later conversion to the desired side-chain chemistry, supporting manufacturing design that separates peptide assembly from final side-chain installation. Resulting intermediates can serve as chemically defined inputs for fine chemical synthesis and specialty chemical production where consistent stereochemical identity and orthogonal functional group behavior are required.

1. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

3. Implications of ligand-receptor binding kinetics on GLP-1R signalling

4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

5. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance